公告显示，此前披露称公司对数字资产业务的潜力和广阔前景具有深刻洞察，将推进数字资产业务的海 外战略发展。配售所得款项可战略投资于数字资产交易所，培育发展链上金融生态，以布局数字资产业 务，构建公司海外战略的核心组成部分。董事会认为，该认购事项符合公司整体战略规划及配售资金用 途安排。通过投资EX.IO，公司可借助其交易所资源与Web3生态技术优势，加快推进海外数字资产业务 布局与市场拓展，进一步增强链上金融服务能力，助力公司业务多元化及可持续发展，为全球化市场布 局奠定坚实基础。 格隆汇9月23日丨九方智投控股(09636.HK)宣布，于2025年9月23日，公司全资子公司JF SmartTrade与目 标公司EX.IO订立股份认购协议，据此，JF SmartTrade同意认购EX.IO股份。 据悉，EX.IO为一家于2023年在开曼群岛注册成立的公司，主要营业地点位于香港，其附属公司EXIO Limited为一家香港持牌虚拟资产交易平台，已于2024年12月获证监会颁发虚拟资产交易平台营运牌 照，主要业务为虚拟资产交易所和虚拟资产托管。 ...

Core Viewpoint - The report from CICC indicates a significant increase in the Total Payment Volume (TPV) for Lianlian Digital, leading to an upward revision of revenue forecasts for 2025 and 2026 by 2% to 1.65 billion and 2.02 billion HKD respectively, while maintaining adjusted profit estimates unchanged [1] Group 1: Financial Performance - In 1H25, Lianlian Digital's revenue increased by 27% year-on-year to 780 million HKD, with net profit turning positive at 151 million HKD compared to a net loss of 350 million HKD in 1H24, largely due to over 1.6 billion HKD in gains from the sale of part of its stake in LianTong [2] - The TPV for 1H25 rose by 32% year-on-year to 2.1 trillion HKD, outpacing the revenue growth of 27% [3] - Gross profit for 1H25 increased by 25% year-on-year to 410 million HKD, maintaining a high gross margin of 52% [4] Group 2: Business Segments - Global payment TPV surged by 94% year-on-year to 198.5 billion HKD, although the overall fee rate declined to 24 basis points due to higher growth in lower-fee service trade and B2B sectors [3] - Domestic payment TPV grew by 28% year-on-year to 1.9 trillion HKD, with a stable fee rate of 1.1 basis points [3] - Value-added services revenue increased by 34% year-on-year to 90 million HKD, primarily driven by contributions from virtual card services [3] Group 3: Strategic Initiatives - The company plans to allocate 50% of the funds raised from placements to enhance blockchain technology applications in cross-border payments, aiming to improve efficiency and security [7] - The company has received approval for the VATP virtual asset trading platform license, which is expected to expand its service capabilities in cross-border payments [7] - The company anticipates steady growth in TPV and payment revenue, projecting a near 700 million HKD in regular operating profit for 2025 [6]

Group 1 - The core viewpoint of the news is that Weixin Jinke (02003) has shown strong financial performance in the first half of 2025, with total revenue reaching 2.5 billion RMB, a year-on-year increase of 43.8%, and a net profit of 216 million RMB, up 79.5% year-on-year [1] - The company plans to distribute an interim dividend of 0.05 HKD per share to reward shareholders for their long-term trust and support [1] - Weixin Jinke has actively adjusted its business strategy to enhance risk control and operational efficiency, aiming to build a safe and compliant digital financial ecosystem [1] Group 2 - Weixin Jinke is expanding its business in emerging technology fields by strategically investing in EXIO Group, one of the first 11 virtual asset trading platforms approved by the Hong Kong Securities and Futures Commission [2] - This investment aims to bridge traditional finance and the Web 3.0 ecosystem, helping Weixin Jinke explore the collaborative value between traditional financial systems and emerging digital asset domains [2] - The company is focused on driving innovation in complex scenarios and establishing higher industry standards in asset security and user experience [2]

Group 1: Stock Market Activity - Today, 35 stocks were listed on the institutional trading list, with 16 stocks seeing net purchases and 19 stocks experiencing net sales [1] - The top three stocks with the highest net purchases by institutions were: Innovation Medical (128 million), Youfang Technology (76.31 million), and Nanmo Biology (56.58 million) [1][2] Group 2: Company Developments - Youfang Technology has announced plans to engage in financing leasing to support its cloud computing services, driven by the growing demand for computing power in the artificial intelligence sector [2] - The company has previously focused on providing cloud infrastructure products to meet customer needs for storage, computing, and transportation [2] Group 3: Brain-Computer Interface Industry - The brain-computer interface product developed by Botuo Bio has entered the clinical trial phase, showing significant recovery effects in the first treated depression patient, with plans to start medical device registration in 2026 [4] - The Chinese government has issued policies to promote innovation in the brain-computer interface industry, with expectations for breakthroughs in key technologies by 2027 [4] - McKinsey predicts that the global market for medical applications of brain-computer interfaces could reach $40 billion by 2030 and $145 billion by 2040, with specific segments for central nervous system disease treatment and emotional assessment [4]